Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,661 | -26,512 | -20,126 | -14,292 | -6,980 |
| Depreciation Amortization | 69 | 308 | 227 | 148 | 73 |
| Accounts receivable | -3,353 | -1,436 | -615 | -519 | -257 |
| Accounts payable and accrued liabilities | -146 | -101 | N/A | N/A | N/A |
| Other Working Capital | -3,655 | -4,466 | -2,803 | -2,192 | -1,727 |
| Other Operating Activity | 4,385 | 4,040 | 2,393 | 1,594 | 708 |
| Operating Cash Flow | $-7,361 | $-28,167 | $-20,924 | $-15,261 | $-8,183 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -95 | -246 | -212 | -149 | -44 |
| Net Acquisitions | N/A | 1,280 | 1,280 | 1,280 | 1,280 |
| Investing Cash Flow | $-95 | $1,034 | $1,068 | $1,131 | $1,236 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 10,000 | N/A | N/A | N/A |
| Common Stock Issued | 40,894 | 48,982 | 43,744 | 40,851 | 40,792 |
| Common Stock Repurchased | N/A | -330 | -172 | N/A | N/A |
| Other Financing Activity | -2,780 | -6,182 | -3,015 | -2,490 | -1,676 |
| Financing Cash Flow | $38,114 | $52,470 | $40,557 | $38,361 | $39,116 |
| Beginning Cash Position | 47,441 | 22,104 | 22,104 | 22,104 | 22,104 |
| End Cash Position | 78,099 | 47,441 | 42,805 | 46,335 | 54,273 |
| Net Cash Flow | $30,658 | $25,337 | $20,701 | $24,231 | $32,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,361 | -28,167 | -20,924 | -15,261 | -8,183 |
| Capital Expenditure | -95 | -246 | -212 | -149 | -44 |
| Free Cash Flow | -7,456 | -28,413 | -21,136 | -15,410 | -8,227 |